FIELD: medicine, pharmacy, chemical-pharmaceutical industry.
SUBSTANCE: invention relates to a method for preparing metoprolol homogenous microparticles that is carried out by treatment of in a fluidized layer. Microparticles have granulometric composition less 250 mcm and comprise at least 80 wt.-% of metoprolol. Metoprolol homogenous microparticles are used for preparing a medicament used in prophylaxis or treatment of cardiovascular disorder. Method is suitable, reproducible and rapid.
EFFECT: improved preparing method.
23 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONTROLLED-RELEASE FORMULATION | 2006 |
|
RU2385712C2 |
| COATED COMPOUND CONTAINING PHARMACEUTICAL AGENT | 2004 |
|
RU2372893C2 |
| PARTICULATE COMPOSITION AND PROCESS FOR OBTAINING IT | 2012 |
|
RU2648353C2 |
| METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
| ORALLY DISINTEGRATING TABLET TEMAZEPAM COMPOSITIONS | 2008 |
|
RU2524638C2 |
| COMPOSITION CONTAINING FINE DISPERSED LONG RELEASING PARTICLES FOR QUICK-DISPOSABLE IN BUCCAL CAVERN TABLETS | 2002 |
|
RU2245136C2 |
| COMPOSITIONS OF ANTIBIOTIC | 2004 |
|
RU2376980C2 |
| PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF ACTIVE SUBSTANCES AND METHOD FOR ITS PREPARING | 2003 |
|
RU2291711C2 |
| PHARMACEUTICAL MEDICINAL FORM, RESISTANT TO GASTRIC JUICE ACTIVITY, WHICH INCLUDES N-(2-(2-PHTHALIMIDOETOXY)ACETYL)-L-ALANYL-D-GLUTAMIC ACID (LK 423) | 2005 |
|
RU2375047C2 |
| CONTROLLED RELEASE SOLID DRUG | 2006 |
|
RU2467740C2 |
